Am­pli­fy the Pa­tient Voice in Clin­i­cal Re­search Tech­nol­o­gy De­vel­op­ment

Last year

The new rules of can­cer care: Re­spond­ing to in­creas­ing CMS in­flu­ence on the on­col­o­gy land­scape

Last year

Pro­tect­ing the glob­al phar­ma­ceu­ti­cal in­no­va­tion ecosys­tem – what’s at stake?

Last year

Achiev­ing Dig­i­tal Trans­for­ma­tion: Un­lock­ing Cost Re­duc­tion, Clin­i­cal Ex­cel­lence & Pre­ci­sion Ther­a­peu­tics Man­u­fac­tur­ing

Last year

Gene Edit­ing Tech­nol­o­gy’s $50 Bil­lion Mar­ket Op­por­tu­ni­ty

3 years ago

How In­smed is Pi­o­neer­ing the Next Fron­tier in Rare Dis­ease R&D

3 years ago

Fortress Bio’s Unique Busi­ness Mod­el Ide­al­ly Suit­ed to Thrive in Biotech’s Bear Mar­ket

3 years ago

Why this bou­tique biotech agency is the fu­ture of clin­i­cal re­cruit­ment

3 years ago

The Fu­ture of Vac­cine Re­search: the Evolv­ing Glob­al Land­scape

3 years ago

Has the mo­ment fi­nal­ly ar­rived for val­ue-based health­care?

3 years ago

Forge Bi­o­log­ics’ cGMP Com­pli­ant and Com­mer­cial­ly Vi­able Be­spoke Affin­i­ty Chro­matog­ra­phy Plat­form

3 years ago

Dig­i­tal ther­a­peu­tics: The key to max­i­miz­ing the po­ten­tial of med­i­c­i­nal as­sets

3 years ago

The Tech-En­abled Mod­el Re­shap­ing Health­care

3 years ago

A New Era of Col­lab­o­ra­tion Promis­es to De­liv­er More Val­ue for Pa­tients

3 years ago

Glob­al Trend Da­ta Shows 50% of New Tri­als Have Sites in Asia Pa­cif­ic

3 years ago

Ad­dress­ing the Un­met Needs of Mi­graine Suf­fer­ers Strug­gling with Men­tal Health Chal­lenges

3 years ago

Strate­gies for Biotechs Plan­ning FDA Ap­proval Path­ways in Cur­rent Fi­nan­cial Mar­ket

3 years ago

2023 Spot­light on the Fu­ture of Drug De­vel­op­ment for Small and Mid-Sized Biotechs

3 years ago

US pol­i­cy and reg­u­la­to­ry changes im­pact­ing com­mer­cial­iza­tion of cell and gene ther­a­pies

3 years ago

In­no­v­a­tive An­a­lyt­i­cal Ul­tra­cen­trifu­ga­tion Tech­niques for the Char­ac­ter­i­za­tion of AAV Vec­tors

3 years ago

Re­flect­ing on More Than a Decade of Progress on mR­NA Sci­ence

3 years ago

Key Trends in Dig­i­tal Ther­a­peu­tics

3 years ago

In­te­grat­ed ev­i­dence gen­er­a­tion 2.0: A strat­e­gy for every stake­hold­er

3 years ago

Pi­o­neer­ing Click Chem­istry in Hu­mans

3 years ago
First page Previous page 1234567 Next page Last page
A service from the Financial Times